Skip to content

Prebiotic Effects in Healthy Toddlers

Double-blind, Randomized Placebo-controlled Trial Investigating Cumulative or Even Synergistic Effects of a Novel Prebiotic Combination in Healthy Toddlers

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05783141
Acronym
PrebiKidz
Enrollment
342
Registered
2023-03-24
Start date
2023-10-01
Completion date
2025-09-30
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Child Development, Diet, Healthy

Keywords

Microbiota, Prebiota, Child´s health

Brief summary

The aim of this study is to demonstrate that a dietary supplementation with a novel prebiotic combination is safe, well tolerated and able to improve overall health of toddlers.

Detailed description

The fermentation of a novel prebiotic combination leads to a modulation of the gut microbiota composition, in particular to a growth stimulation of bifidobacteria, and the production of organic acids like lactate and short-chain fatty acids (SCFA).The efficacy of the prebiotic combination to improve toddler's digestive function will be addressed. The overall health will be assessed as a measure of reduced number of febrile days resulting in less days of absenteeism from daycare centers.

Interventions

DIETARY_SUPPLEMENTNew prebiotic follow-on formula, randomly assigned to healthy toddlers

Standard follow-on formula administered orally

DIETARY_SUPPLEMENTStandard follow-on formula, randomly assigned to healthy toddlers

Standard follow-on formula administered orally

Sponsors

Universitair Ziekenhuis Brussel
CollaboratorOTHER
Beneo-Institute
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
10 Months to 36 Months
Healthy volunteers
Yes

Inclusion criteria

1. Child is healthy at the time of pre-examination 2. Child is aged between 10-36 months and attends a day care center for the duration of the intervention 3. Child attends a daycare center at the time of pre examination for at least 50%. 4. Child presents a normal defecation characteristic (according to Brussels Infant and Toddler Stool scale) 5. Weight for height z-score \>-2 and \<2 SD based on Flemish growth charts 6. Child and legal guardian are able and willing to follow the study instructions 7. Child is suitable for participation in the study according to the investigator/ study personnel 8. Informed written consent given by parent / legal guardian

Exclusion criteria

1. No legal guardian's command of any local language 2. Child with any chronic disorder or disease, e.g., defecation disorders (incl. Hirschsprung and celiac disease) metabolic or renal abnormalities as well as mental or psychomotor retardation (incl. child´s mental delay and hypotonia) 3. Child is suffering from congenital or acquired immunodeficiency 4. Food allergies or intolerances 5. Child is currently breast-fed more than once daily 6. Use of drugs (e.g. antibiotics) influencing gastrointestinal function (6 weeks before intervention) 7. Use of laxatives (4 weeks before intervention) as well as probiotic and prebiotic food supplements. Follow-on formula with L. Reuteri and/or GOS/FOS/HMO is allowed. 8. Child is suffering from an infection at the time of pre examination or previous 7 days 9. Child is currently involved or will be involved in another clinical or food study 10. Child is not suitable for participation in the study according to the study personnel´s opinion

Design outcomes

Primary

MeasureTime frameDescription
FeverData collected continuously from enrollment until end of intervention (up to 90 days).Number of febrile days (peak temperature of forehead at least 38.0°C)
AbsenteeismData collected continuously from enrollment until end of intervention (up to 90 days).Number of days of child´s absence from day care center due to infectious episodes or antibiotic treatment.

Secondary

MeasureTime frameDescription
Beneficial colonizationStool sample collected at baseline and after 90 days intervention periodChanges in fecal microbiota by 16S rRNA Sequencing
Stool consistencyData collected continuously from enrollment until end of intervention (up to 90 days).Hard, formed, soft and watery stools will be assessed by the parents and day care centers in a continuous daily bowel diary using the Brussels Infant and Toddler Stool Scale
Stool frequencyData collected continuously from enrollment until end of intervention (up to 90 days).Number of defecations will be assessed by the parents and day care centers in a continuous daily bowel diary using the Brussels Infant and Toddler Stool Scale
Caretaker´s absenteeism from workData collected continuously from enrollment until end of intervention (up to 90 days).Number of work days missed by the parents

Countries

Belgium

Contacts

Primary ContactStephan Theis, Dr
Stephan.Theis@beneo.com+496359803287
Backup ContactMaria Pudenz, Dr.
maria.pudenz@beneo.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026